[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
July 19, 2006

Antiretroviral Therapy for ChildrenSubstantial Benefit But Limited Access

Author Affiliations
 

Author Affiliations: Division of Infectious Diseases, Departments Medicine and Pediatrics, Brown Medical School, Rhode Island and Miriam Hospitals, Providence (Dr Harwell) and Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pa (Dr Obaro).

JAMA. 2006;296(3):330-331. doi:10.1001/jama.296.3.330

According to the United Nations Programme on HIV/AIDS (UNAIDS) global report on human immunodeficiency virus (HIV), in 2005 more than 2.3 million children were living with HIV infection, and 380 000 children with HIV had died.1 Most of the children who die from HIV have severe manifestations of common childhood illnesses, such as diarrhea, malnutrition, acute respiratory tract infection, and tuberculosis.24 These children often die before the diagnosis of HIV infection can be made, and mortality is often attributed to a background high rate of early childhood mortality.

First Page Preview View Large
First page PDF preview
First page PDF preview
×